ATOSSA THERAPEUTICS, INC.
Nasdaq · CIK 0001488039 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224521 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224148 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224140 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224135 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224133 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-05-14 | 0001193125-26-224125 |
| 10-Q | ATOSSA THERAPEUTICS, INC. | 2026-05-08 | 0001193125-26-213423 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-03-31 | 0001193125-26-134861 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-03-30 | 0001193125-26-132644 |
| 10-K | ATOSSA THERAPEUTICS, INC. | 2026-03-25 | 0001193125-26-124396 |
| 4 | ATOSSA THERAPEUTICS, INC. | 2026-01-22 | 0001193125-26-019273 |
| 10-Q | ATOSSA THERAPEUTICS, INC. | 2025-11-12 | 0001193125-25-276160 |
| 10-Q | ATOSSA THERAPEUTICS, INC. | 2025-08-12 | 0000950170-25-106947 |